Hartford Financial Management’s VistaGen Therapeutics VTGN Stock Holding History

Hartford Financial Management’s Portfolio VTGN Stock Details VTGN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q2	–	Sell	-533	Closed	-$2K	–	381
2023 Q1	$2K	Hold	533	–	–	﹤0.01%	348
2022 Q4	$1.65K	Hold	533	–	–	﹤0.01%	353
2022 Q3	$2K	Hold	533	–	–	﹤0.01%	362
2022 Q2	$14K	Hold	533	–	–	﹤0.01%	264
2022 Q1	$20K	Hold	533	–	–	﹤0.01%	256
2021 Q4	$31K	Hold	533	–	–	0.01%	238
2021 Q3	$44K	Hold	533	–	–	0.01%	216
2021 Q2	$50K	Hold	533	–	–	0.01%	207
2021 Q1	$34K	Hold	533	–	–	0.01%	222
2020 Q4	$31K	Hold	533	–	–	0.01%	227
2020 Q3	$11K	Hold	533	–	–	﹤0.01%	260
2020 Q2	$8K	Hold	533	–	–	﹤0.01%	276
2020 Q1	$7K	Hold	533	–	–	﹤0.01%	282
2019 Q4	$11K	Hold	533	–	–	﹤0.01%	289
2019 Q3	$17K	Hold	533	–	–	0.01%	272
2019 Q2	$12K	Buy	533 +66	+14%	+$1.75K	﹤0.01%	289
2019 Q1	$18K	Buy	+467	New	+$20.4K	0.01%	270
2018 Q1	–	Sell	-43	Closed	-$1K	–	363
2017 Q4	$1K	Hold	43	–	–	﹤0.01%	338
2017 Q3	$2K	Hold	43	–	–	﹤0.01%	372
2017 Q2	$2K	Hold	43	–	–	﹤0.01%	352
2017 Q1	$2K	Hold	43	–	–	﹤0.01%	332
2016 Q4	$5K	Hold	43	–	–	﹤0.01%	280
2016 Q3	$5K	Buy	43 +6	+16%	+$652	﹤0.01%	275
2016 Q2	$4K	Buy	+37	New	+$4.24K	﹤0.01%	260

Other funds holding VTGN

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

GCP

GSA Capital Partners London, United Kingdom $1.61B AUM 28.28% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

YIH

Y-Intercept (HK) Hong Kong $5.05B AUM 17.89% 1-Year Est. Return

CSS

Cubist Systematic Strategies Stamford, Connecticut $21B AUM 21.48% 1-Year Est. Return

RhumbLine Advisers Boston, Massachusetts $117B AUM 29.66% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Hartford Financial Management's VTGN Position: Q2 2023 in Review

Hartford Financial Management sold out of VistaGen Therapeutics (VTGN) in Q2 2023, closing a stake of 533 shares — an estimated $2K sold.

Hartford Financial Management first reported a position in VTGN in Q2 2016 and held it in 24 quarters. The position peaked at $50K in Q2 2021. 33 funds tracked by Wall St. Rank hold VTGN as of Q2 2023.

Hartford Financial Management reported no remaining VistaGen Therapeutics position as of Q2 2023 after selling out during the quarter.
Hartford Financial Management sold 533 VistaGen Therapeutics shares in Q2 2023, an estimated $2K.
Hartford Financial Management first reported a position in VistaGen Therapeutics in Q2 2016 and held it in 24 quarters.
Hartford Financial Management's VistaGen Therapeutics position peaked at $50K in Q2 2021.
33 funds tracked by Wall St. Rank held VistaGen Therapeutics as of Q2 2023.

Based on Hartford Financial Management's 13F filing for Q2 2023, filed 27 Jul 2023.